- Home
- VERV vs STAA Comparison
VERV vs STAA Comparison
Compare VERV & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- STAA
- Stock Information
- Founded
- VERV 2018
- STAA 1982
- Country
- VERV United States
- STAA United States
- Employees
- VERV N/A
- STAA N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- STAA Ophthalmic Goods
- Sector
- VERV Health Care
- STAA Health Care
- Exchange
- VERV Nasdaq
- STAA Nasdaq
- Market Cap
- VERV 1.0B
- STAA 850.9M
- IPO Year
- VERV 2021
- STAA N/A
- Fundamental
- Price
- VERV $11.06
- STAA $17.17
- Analyst Decision
- VERV Buy
- STAA Hold
- Analyst Count
- VERV 11
- STAA 8
- Target Price
- VERV $14.57
- STAA $27.17
- AVG Volume (30 Days)
- VERV 7.6M
- STAA 746.9K
- Earning Date
- VERV 08-07-2025
- STAA 08-06-2025
- Dividend Yield
- VERV N/A
- STAA N/A
- EPS Growth
- VERV N/A
- STAA N/A
- EPS
- VERV N/A
- STAA N/A
- Revenue
- VERV $59,613,000.00
- STAA $279,134,000.00
- Revenue This Year
- VERV $47.32
- STAA N/A
- Revenue Next Year
- VERV N/A
- STAA $29.34
- P/E Ratio
- VERV N/A
- STAA N/A
- Revenue Growth
- VERV 271.44
- STAA N/A
- 52 Week Low
- VERV $2.87
- STAA $13.50
- 52 Week High
- VERV $11.41
- STAA $49.86
- Technical
- Relative Strength Index (RSI)
- VERV 78.23
- STAA 49.02
- Support Level
- VERV $11.16
- STAA $16.52
- Resistance Level
- VERV $11.30
- STAA $18.00
- Average True Range (ATR)
- VERV 0.12
- STAA 0.69
- MACD
- VERV -0.18
- STAA 0.09
- Stochastic Oscillator
- VERV 12.50
- STAA 53.85
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.